Neurociencias
Departamento
Pfizer (United States)
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Pfizer (United States) (2)
2012
-
Elucidating the mechanism of action of pregabalin: α 2δ as a therapeutic target in Anxiety
CNS Drugs, Vol. 26, Núm. 8, pp. 637-648
-
The cost of generalized anxiety disorder in primary care settings: Results of the ANCORA study
Community Mental Health Journal, Vol. 48, Núm. 3, pp. 372-383